Skip to main content
Premium Trial:

Request an Annual Quote

Dresdner Kleinwort Wasserstein Begins Coverage of Genomic Sector

NEW YORK, Sept. 26 - Dresdner Kleinwort Wasserstein has begun covering a handful of “special niche” genomic and proteomic companies, the financial company said on Wednesday.

The coverage, which will be led by analyst Charles C. Duncan, will include Celgene, CuraGen, Exelixis, Human Genome Sciences, Millennium Pharmaceuticals, Myriad Genetics, Tularik, and Vertex Pharmaceuticals. These all were rated a “Buy,” the company said in a statement. Two more companies, Celera Genomics and Sangamo BioSciences, were rated an “Add.”

Duncan, who directs Dresdner Kleinwort Wasserstein's Equity Research Division in New York, has identified these companies, which he explained in a statement “stand at a productivity inflection point.”

“These companies make up a small group of established firms that … have fully adopted the use of genomic information and the new tools of biology and … have shown early successes in establishing the potential for multiple product development—both of which are key to generating superior rates of return for investors over the coming years,” Duncan said.

“We are recommending investment in companies with excellent product development capabilities, a long list of product-oriented news flow, and truly exciting growth prospects. Moreover, as drug developers, these companies are relatively ‘recession-resistant,’” he added.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.